Matt Hancock, the health secretary, has announced that he is making ₤ 20m readily available to an Oxford team to accelerate trials for a coronavirus vaccine that will be trialed on people from today April 23, 2020.
A vaccine for coronavirus is the breakthrough the world is awaiting. It would offer humankind a method to beat the infection and conserve lives.
Lots of clinical groups in various nations are chasing this objective, and Health Secretary Matt Hancock hopes the UK will be the one to be successful.
He’s promised ₤ 42.5 m to fund two research study groups: one team at Imperial College London and the other based at Oxford University.
The Oxford group, led by Prof Sarah Gilbert, is to start evaluating its vaccine in human volunteers this week.
Her group at the Jenner Institute set to work as soon as the genetic code, or blueprint, of coronavirus, appeared in January.
ALSO READ: Western-North region records first COVID-19 case
The vaccine utilizes a little area of this code packaged into a harmless virus. Researchers hope that delivering this into the body will teach the body immune system how to combat off the genuine illness, without ever requiring to become infected with the coronavirus.
The plan is to check it on around 500 volunteers by mid-May and if that work proves effective, give it to thousands of more volunteers.
Other groups, like Prof Robin Shattock and colleagues at Imperial, are using pieces of raw genetic code which, as soon as injected into the body, need to begin producing bits of viral proteins in which the immune system once again can discover to combat.
